Zdrowie i gospodarka · 09/03/2020

FDA Releases Draft Guidance on Contact Dermatitis from Topical Drug Products for Cutaneous Application

The Food and Drug Administration (FDA) has released a draft guidance for industry on assessing the human safety of topical drug products for cutaneous application, specifically addressing the risk of contact dermatitis. The guidance provides recommendations for product development.